Featured clinical trials
Now recruiting at this location
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
A Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.
Research study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
-
-
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
-
Navigation
-
Locations
T: 1300 742 326